RVMD — Revolution Medicines Inc

Ownership history in Column Group LLC  ·  21 quarters on record

This page tracks every 13F SEC filing in which Column Group LLC reported a position in Revolution Medicines Inc (RVMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
36.3% (2022 Q4)
Avg. % of fund
11.48%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 46 — 0% 0.00% $4K $79.65
2025 Q3 UNCHANGED 46 — 0% 0.00% $2K $46.70
2025 Q2 UNCHANGED 46 — 0% 0.00% $2K $36.79
2025 Q1 UNCHANGED 46 — 0% 0.00% $2K $35.36
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RVMD price (monthly, adj. close)

Other funds also holding RVMD

As of 2025 Q4 — sorted by position size

AIHC Capital Management Ltd 67.21% Park Avenue Institutional Advisers LLC 3Y 7Y 40.5% Paradigm Biocapital Advisors LP 3Y 13.51% Casdin Capital, LLC 3Y 7Y 12.75% DAFNA Capital Management LLC 3Y 7Y 11.18% Alphabet Inc. 3Y 10.33% Logos Global Management LP 3Y 9.63% Checkpoint Capital L.P. 9.21% MIC Capital Management UK LLP 3Y 9.18% BVF INC/IL 3Y 7Y 9.0%
← Back to Column Group LLC Holdings